**Core Concept**
The question is testing the knowledge of a clinical test used to assess hepatic function and its relation to bleeding disorders. The liver plays a crucial role in the production of clotting factors, and impaired liver function can lead to coagulopathy.

**Why the Correct Answer is Right**
The correct answer is a test that evaluates the liver's ability to synthesize clotting factors. The liver produces most of the coagulation factors, including prothrombin (factor II), fibrinogen (factor I), and factors VII, IX, and X. Impaired liver function can lead to a decrease in these clotting factors, resulting in coagulopathy. The test used to assess this is the **Prothrombin Time (PT)** or **International Normalized Ratio (INR)**, which measures the time it takes for blood to clot. Elevated PT or INR values indicate poor liver function and an increased risk of bleeding.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to the assessment of hepatic function or bleeding disorders.
* **Option B:** This option is not a direct measure of hepatic function or clotting factor synthesis.
* **Option C:** This option is not a specific test for assessing hepatic function or bleeding disorders.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that impaired liver function can lead to a decrease in clotting factors, resulting in coagulopathy. This is why patients with liver disease are at an increased risk of bleeding.

**Correct Answer:** C.